THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Yakira Capital Management, Inc.'s Holding History (CIK: 0001584639)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 12,622 Value ($000) $184 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 12,622 Value ($000) $139 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 15,122 Value ($000) $135 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 15,122 Value ($000) $142 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 15,122 Value ($000) $122 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 15,122 Value ($000) $128 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 15,122 Value ($000) $136 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 15,122 Value ($000) $170 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 16,898 Value ($000) $146 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 16,898 Value ($000) $175 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 32,656 Value ($000) $354 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 31,528 Value ($000) $354 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 59,100 Value ($000) $599 Avg Close $9.37 Range $7.53 - $11.00